FDA Audited, PBMC Services Company Trusted By Leading Biotech for Over 20 Years!

Peripheral Blood Mononuclear Cells (PBMCs) are blood cells with a single round nucleus, including lymphocytes (T cells, B cells, NK cells) and monocytes. PBMCs play a crucial role in the immune response and are essential for various research applications in immunology, cancer research, and biomarker discovery.

PBMC Analysis is a technique that measures the characteristics and composition of PBMCs, helping researchers identify and quantify specific cell populations, determine their functions, and study their interactions. It’s crucial in fields like immunology, cancer research, and drug development.

PBMCs are extensively used in immunological studies, cancer research, biomarker discovery, drug development, and clinical trials. They help researchers understand immune cell behavior, evaluate drug efficacy and safety, and identify potential therapeutic targets.

PBMCs are typically isolated from blood samples using density gradient centrifugation, a method that separates mononuclear cells from other blood components like red blood cells and granulocytes based on their density. Alternatively, Leukopak PBMC isolation is used for obtaining large volumes of high-purity PBMCs from leukapheresis products.

PBMC processing includes steps such as sample collection, PBMC isolation, cell counting, viability assessment, and preparation for downstream applications like culture, analysis, or storage. Proper processing ensures the integrity and functionality of PBMCs for accurate research outcomes.

PBMCs are cultured in specialized media that provide the necessary nutrients and growth factors to maintain cell viability and function. Conditions such as temperature, CO₂ levels, and humidity are carefully controlled to support long-term studies and functional assays.

A specialized PBMC lab offers services including:

• PBMC isolation and processing
• Cell culture
• Method development and validation
• Bioanalytical assays
• Biomarker testing
• GLP (Good Laboratory Practices) validation
• Comprehensive analysis for preclinical and clinical research

PBMC assays include:

• Flow Cytometry for cell population analysis
• Mass Spectrometry (LC-MS, high-resolution MS) for biomolecule profiling
• ELISA for cytokine detection
• PCR for gene expression studies
• Functional Assays to assess immune responses and cell interactions

PBMC testing is conducted using validated methods under Good Laboratory Practices (GLP) and Good Clinical Practices (GCP). Techniques such as flow cytometry, mass spectrometry, and PCR are employed with rigorous quality controls to ensure accurate and reliable results.

Professional PBMC services companies offer:

• Expertise and high-quality methodologies
• State-of-the-art equipment
• Fast turnaround times
• Compliance with regulatory standards
• Reliable and consistent results are crucial for advancing therapeutic development and research

PBMC services support drug development by:

• Providing insights into immune responses
• Characterizing drug interactions
• Evaluating safety and efficacy
• Facilitating biomarker discovery This accelerates the drug discovery process and enhances the understanding of therapeutic effects.

• Isolation: Density gradient centrifugation, leukapheresis
• Analysis: Flow cytometry, mass spectrometry (LC-MS, high-resolution MS), PCR-based assays, ELISA

GLP (Good Laboratory Practices) validation ensures that PBMC methods and assays are reliable, reproducible, and compliant with regulatory standards. This is essential for supporting clinical trials, regulatory submissions, and maintaining data integrity in research studies.

Human PBMC cells are used to:

• Study immune responses
• Monitor patient health
• Evaluate therapeutic interventions
• Identify biomarkers for diseases They provide valuable insights into the immune system’s behavior in various clinical settings.

In immunology studies, PBMCs are used to investigate immune cell function, interactions, and responses to pathogens or treatments. They help in understanding disease mechanisms, developing vaccines, and designing immunotherapies.

Yes, PBMCs can be cultured and maintained in controlled environments for long-term studies. PBMC culture techniques allow for the expansion and preservation of viable cells, enabling extended research on immune responses and therapeutic effects.

Turnaround times for PBMC services vary based on the specific requirements and complexity of the analysis. Professional service providers prioritize fast and efficient processing to meet research deadlines while maintaining high-quality standards.

NorthEast BioLab adheres to:

• Good Laboratory Practices (GLP)
• Good Clinical Practices (GCP)
• GRegulatory requirements of FDA, EMA, and other agencies

NorthEast BioLab has over 20 years of industry-leading experience in PBMC services, having developed and validated hundreds of PBMC methods for various applications.

Yes, NorthEast BioLab specializes in tailoring its services to meet specific client needs, offering flexible and responsive support for various research and therapeutic development projects.

NorthEast BioLab can analyze PBMCs from various sources, supporting both preclinical and clinical studies across different research areas including immunology, drug development, and biomarker discovery.

PBMCs play a vital role in clinical research due to their involvement in the immune system. They are used to:

• Study Immune Responses: Understanding how the immune system reacts to diseases, vaccines, and therapies.
• Biomarker Discovery: Identifying indicators for disease progression and treatment efficacy.
• Therapeutic Development: Evaluating the effectiveness and safety of new drugs and treatments.
• Disease Mechanism Exploration: Investigating how diseases affect immune cell function and interactions.

PBMCs can be sourced from various biospecimens, including:

• Whole Blood: The most common source, typically collected via venipuncture.
• Leukapheresis Products: A process that concentrates white blood cells from blood, providing larger volumes of PBMCs.
• Cord Blood: Collected from the umbilical cord, offering a rich source of stem cells and PBMCs.
• Bone Marrow: Although less common, PBMCs can also be derived from bone marrow samples.

Several methods are employed to isolate PBMCs from blood samples:

• Density Gradient Centrifugation: Uses solutions like Ficoll-Paque to separate PBMCs based on their density.
• Leukapheresis: A specialized technique that separates and collects PBMCs from a larger volume of blood.
• Magnetic-Activated Cell Sorting (MACS): Utilizes magnetic beads attached to antibodies targeting specific PBMC subsets for isolation.
• Flow Cytometry-Based Sorting: Separates PBMCs based on their physical and chemical properties using fluorescence markers.

Proper counting and freezing of PBMCs are essential for maintaining cell viability and functionality:

• Counting PBMCs:
  • Manual Counting: Using a hemocytometer under a microscope.
  • Automated Cell Counters: Utilizing devices like flow cytometers for accurate and efficient cell counts.
  • Viability Assessment: Employing trypan blue exclusion or other viability dyes to ensure cell health.
• Freezing PBMCs:
  • Cryopreservation Media: Typically involves a mixture of dimethyl sulfoxide (DMSO) and fetal bovine serum (FBS) to protect cells during freezing.
  • Controlled Rate Freezing: Gradually lowering the temperature using a controlled-rate freezer or a freezing container to prevent ice crystal formation.
  • Storage: Transfer frozen PBMCs to liquid nitrogen tanks for long-term preservation.

Ensuring high-quality PBMCs is crucial for reliable research outcomes. Here are common issues and troubleshooting tips:

• Low Cell Viability:
  • Cause: Prolonged storage, improper handling, or suboptimal freezing protocols.
  • Solution: Optimize cryopreservation techniques, minimize freeze-thaw cycles, and use viability-enhancing media.
• Contamination:
  • Cause: Bacterial, fungal, or endotoxin contamination during isolation or culture.
  • Solution: Maintain sterile techniques, use antibiotics if appropriate, and ensure all reagents and equipment are sterile.
• Low Yield:
  • Cause: Inefficient isolation methods or poor-quality starting material.
  • Solution: Refine isolation protocols, use higher-quality samples, and consider alternative isolation techniques like leukapheresis for better yields.
• Functional Impairment:
  • Cause: Stress from handling, suboptimal culture conditions, or cryopreservation damage.
  • Solution: Optimize culture conditions, handle cells gently, and use protective agents during freezing to maintain functionality.